Oriven (Venlafaxine)

Venlafaxine, the active ingredient in Oriven, is a serotonin‑norepinephrine reuptake inhibitor (SNRI) presented as a tablet for oral use. It is prescribed for major depressive disorder and other mood conditions in adults. GNH USA supplies Oriven as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Venlafaxine acts on neurotransmitter pathways that influence mood and anxiety. It is indicated for several psychiatric conditions: - Major Depressive Disorder: alleviates depressive symptoms and improves functional outcomes. - Generalized Anxiety Disorder: reduces excessive worry and associated physical symptoms. - Social Anxiety Disorder: helps decrease fear of social situations and improves social functioning. - Panic Disorder: lessens the frequency and intensity of panic attacks. - Fibromyalgia (off‑label in some regions): may reduce pain and fatigue associated with the condition.

Venlafaxine may cause a range of adverse reactions. Patients should be aware of both frequent and less common events.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Headache: tension‑type or throbbing pain. - Dry mouth: reduced salivation. - Insomnia: difficulty falling or staying asleep. - Sweating: increased perspiration, especially at night. - Dizziness: light‑headed sensation, often positional.

Serious or Rare Side Effects: - Hypertensive crisis: sudden, severe rise in blood pressure. - Serotonin syndrome: agitation, hyperthermia, muscle rigidity. - Suicidal thoughts: emergence of new or worsening ideation. - Severe liver injury: jaundice, elevated enzymes. - Cardiac arrhythmias: irregular heart rhythm. - Allergic reaction: rash, swelling, anaphylaxis.

Before starting Venlafaxine, clinicians should evaluate several safety factors: - Cardiovascular assessment: monitor blood pressure and heart rate regularly. - Psychiatric monitoring: watch for worsening depression or emergence of suicidal thoughts. - Drug discontinuation: taper gradually to avoid discontinuation syndrome. - Pregnancy and lactation: weigh potential benefits against risks; discuss with obstetrician. - Liver and kidney function: adjust if significant impairment is present. Store below 25°C: keep in the original container, protect from moisture and direct sunlight.

Venlafaxine can interact with a variety of medicines, altering efficacy or safety. Awareness of key interactions helps prevent adverse events.

Major Interactions (Avoid): - MAO inhibitors: risk of serotonin syndrome; a 14‑day washout is required. - Triplet antihypertensives (e.g., clonidine): may cause severe hypertension. - Serotonergic opioids (e.g., tramadol): increase serotonin toxicity risk.

Moderate Interactions (Monitor Closely): - CYP2D6 inhibitors (e.g., fluoxetine, paroxetine): raise venlafaxine levels. - NSAIDs or anticoagulants: heightened bleeding tendency. - Anticholinergic agents: additive dry‑mouth and constipation effects.